Share:
Peer-Reviewed Publication
Endocrinol Metab (Seoul)2026;41(2):319-332.April 1, 2026Journal Article

Muscle Loss Driven by Extracellular Signal-Regulated Kinase Suppression via β-Adrenergic Activation in High-Normal Catecholamine Status.

Jieun Lee1,2, Ju Yeon Kwak1,3,4, Ho Yeop Lee1,3, Ji Sun Moon1, Hyo Ju Jang1,3, Ha Thi Nga1,3, Thi Linh Nguyen1,3, Alfin Mohammad Abdillah1,3, Junglyun Kim2, Sihwan Kim5,6, Yong Ryoul Yang4, Jeong Eun Lee7, Hyon-Seung Yi8,9
1Laboratory of Endocrinology and Immune System, Chungnam National University College of Medicine, Daejeon, Korea.
2Chungnam National University College of Nursing, Daejeon, Korea.
3Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea.
4Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
5Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
6ClariPi Research, ClariPi, Seoul, Korea.
7Department of Radiology, Chungnam National University Hospital, Daejeon, Korea. nasa80@cnuh.co.kr.
8Laboratory of Endocrinology and Immune System, Chungnam National University College of Medicine, Daejeon, Korea. jmpbooks@cnu.ac.kr.
9Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea. jmpbooks@cnu.ac.kr.

Abstract

BACKGRUOUND: Catecholamines play a crucial role in muscle biogenesis, but their persistent elevation is linked to muscle wasting, which is poorly understood. This study aimed to investigate the association between catecholamine levels and age-related muscle loss. METHODS: This retrospective study evaluated the plasma levels of two catecholamines, metanephrine and normetanephrine, and the clinical…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.